mBio (Feb 2021)

SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike

  • Jenna J. Guthmiller,
  • Olivia Stovicek,
  • Jiaolong Wang,
  • Siriruk Changrob,
  • Lei Li,
  • Peter Halfmann,
  • Nai-Ying Zheng,
  • Henry Utset,
  • Christopher T. Stamper,
  • Haley L. Dugan,
  • William D. Miller,
  • Min Huang,
  • Ya-Nan Dai,
  • Christopher A. Nelson,
  • Paige D. Hall,
  • Maud Jansen,
  • Kumaran Shanmugarajah,
  • Jessica S. Donington,
  • Florian Krammer,
  • Daved H. Fremont,
  • Andrzej Joachimiak,
  • Yoshihiro Kawaoka,
  • Vera Tesic,
  • Maria Lucia Madariaga,
  • Patrick C. Wilson

DOI
https://doi.org/10.1128/mBio.02940-20
Journal volume & issue
Vol. 12, no. 1

Abstract

Read online

With the ongoing pandemic, it is critical to understand how natural immunity against SARS-CoV-2 and COVID-19 develops. We have identified that subjects with more severe COVID-19 disease mount a more robust and neutralizing antibody response against SARS-CoV-2 spike protein.